These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38228990)

  • 1. Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study.
    Wyte-Lake T; Cohen DJ; Williams S; Casey D; Chan M; Frank B; Levander XA; Stein D; White KK; Bailey SR
    J Gen Intern Med; 2024 Jan; ():. PubMed ID: 38228990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Telehealth for Opioid Use Disorder Treatment in Safety Net Primary Care Settings: A Mixed-Methods Study.
    Bailey SR; Wyte-Lake T; Lucas JA; Williams S; Cantone RE; Garvey BT; Hallock-Koppelman L; Angier H; Cohen DJ
    Subst Use Misuse; 2023; 58(9):1143-1151. PubMed ID: 37170596
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis.
    Couch JV; Whitcomb M; Buchheit BM; Dorr DA; Malinoski DJ; Korthuis PT; Ono SS; Levander XA
    Harm Reduct J; 2024 Jun; 21(1):125. PubMed ID: 38937779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Perceptions of Audio-Only Versus Video Telehealth Visits: A Qualitative Study Among Patients in an Academic Medical Center Setting.
    Kruis R; Brown EA; Johnson J; Simpson KN; McElligott J; Harvey J
    Telemed Rep; 2024; 5(1):89-98. PubMed ID: 38595727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.
    Frost MC; Zhang L; Kim HM; Lin LA
    JAMA Netw Open; 2022 Oct; 5(10):e2236298. PubMed ID: 36223118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions and Use of Telehealth Among Mental Health, Primary, and Specialty Care Clinicians During the COVID-19 Pandemic.
    Connolly SL; Miller CJ; Gifford AL; Charness ME
    JAMA Netw Open; 2022 Jun; 5(6):e2216401. PubMed ID: 35671053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation.
    Lott AM; Danner AN; Malte CA; Williams EC; Gordon AJ; Halvorson MA; Saxon AJ; Hagedorn HJ; Sayre GG; Hawkins EJ
    J Addict Med; 2023 Jul-Aug 01; 17(4):e262-e268. PubMed ID: 37579107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to MAT: Participants' Experiences With Transportation, Non-Emergency Transportation, and Telehealth.
    Boyd J; Carter M; Baus A
    J Prim Care Community Health; 2024; 15():21501319241233198. PubMed ID: 38420885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of VA's video telehealth tablets on substance use disorder care during the COVID-19 pandemic.
    Gujral K; Van Campen J; Jacobs J; Kimerling R; Zulman DM; Blonigen D
    J Subst Use Addict Treat; 2023 Jul; 150():209067. PubMed ID: 37164153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telehealth and delivery of alcohol use disorder treatment in the Veterans Health Administration.
    Perumalswami PV; Adams MA; Frost MC; Holleman R; Kim HM; Zhang L; Lin LA
    Alcohol Clin Exp Res (Hoboken); 2024 May; 48(5):944-954. PubMed ID: 38529689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: A multi-method study.
    Thomas EE; de Camargo Catapan S; Haydon HM; Barras M; Snoswell C
    Res Social Adm Pharm; 2022 Sep; 18(9):3602-3611. PubMed ID: 35183460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient experiences with telehealth treatment for opioid use disorder in Alabama.
    Weiner SG; Burgess A; Singh H; Miller EN; Murphy C; Chehregosha E; Clear B
    J Subst Use Addict Treat; 2024 Jul; 165():209451. PubMed ID: 38960146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.
    Uscher-Pines L; Sousa J; Raja P; Mehrotra A; Barnett M; Huskamp HA
    J Subst Abuse Treat; 2020 Nov; 118():108124. PubMed ID: 32893047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.
    Hailu R; Mehrotra A; Huskamp HA; Busch AB; Barnett ML
    JAMA Netw Open; 2023 Jan; 6(1):e2252381. PubMed ID: 36692880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on Telephone and Video Communication in the Intensive Care Unit during COVID-19.
    Kennedy NR; Steinberg A; Arnold RM; Doshi AA; White DB; DeLair W; Nigra K; Elmer J
    Ann Am Thorac Soc; 2021 May; 18(5):838-847. PubMed ID: 33181033
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of telemedicine for opioid use disorder treatment - Perceptions and experiences of opioid use disorder clinicians.
    Riedel L; Uscher-Pines L; Mehrotra A; Busch AB; Barnett ML; Raja P; Huskamp HA
    Drug Alcohol Depend; 2021 Nov; 228():108999. PubMed ID: 34517225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Patients' Preferences and Perceptions of Advantages and Disadvantages of Telehealth Visits During the COVID-19 Pandemic.
    Kumar D; Gordon N; Zamani C; Sheehan T; Martin E; Egorova O; Payne J; Kolevska T; Neeman E; Liu R
    JCO Clin Cancer Inform; 2023 Sep; 7():e2300040. PubMed ID: 37656925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics.
    Austin EJ; Briggs ES; Ferro L; Barry P; Heald A; Curran GM; Saxon AJ; Fortney J; Ratzliff AD; Williams EC
    J Gen Intern Med; 2023 Feb; 38(2):332-340. PubMed ID: 35614169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.
    Mattocks KM; Moore DT; Wischik DL; Lazar CM; Rosen MI
    J Subst Abuse Treat; 2022 Aug; 139():108777. PubMed ID: 35346533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians.
    Huskamp HA; Riedel L; Campa I; Busch AB; Rose S; Mehrotra A; Uscher-Pines L
    J Gen Intern Med; 2023 Jul; 38(9):2139-2146. PubMed ID: 36964424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.